13953578 C-265 C 265 An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access) Loi modifiant la Loi sur les aliments et drogues (Liste des produits thérapeutiques préapprouvés aux fins d’accès spécial) An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access) 352 At consideration in committee in the House of Commons À l'examen en comité à la Chambre des communes At consideration in committee in the House of Commons 60044 Second reading Deuxième lecture Second reading Second reading in the House of Commons false 1 House of Commons Chambre des communes House of Commons 60049 Consideration in committee Examen en comité Consideration in committee 60030 Second reading Deuxième lecture Second reading 1 House of Commons Chambre des communes House of Commons 2026-06-10T18:30:21.24 45 1 4 Private Member’s Bill Projet de loi émanant d'un député Private Member’s Bill false 1 House of Commons Chambre des communes House of Commons true false 105437 Marcus Powlowski Marcus Powlowski Member of Parliament député Member of Parliament 2 Member of Parliament député(e) Member of Parliament 1159 Thunder Bay—Rainy River Thunder Bay—Rainy River Thunder Bay—Rainy River 60121 Second reading and referral to committee Deuxième lecture et renvoi en comité 60030 Second reading and referral to committee 0 30564 Standing Committee on Health Comité permanent de la santé HESA Standing Committee on Health false true false false 2026-06-10T14:00:00 1 House of Commons Chambre des communes House of Commons 0 0 133 2026-03-11T15:38:50.27 2026-06-10T18:30:21.24 false false true true false false false false false false false 10 Regular Ordinaire Regular false 0 60029 First reading Première lecture First reading 1 45 1 4 Completed Terminée 2026-03-11T15:38:50.27 Completed Introduction and first reading Dépôt et première lecture Introduction and first reading 94 2026-03-11T00:00:00 true 60110 0 Introduction and first reading Dépôt et première lecture Introduction and first reading 2026-03-11T00:00:00 true false 60110 Introduction and first reading Dépôt et première lecture Introduction and first reading 2026-03-11T15:38:50.27 2026-03-11T15:38:50.27 1 2026-03-11T15:38:50.27 false false 60030 Second reading Deuxième lecture Second reading 1 45 1 4 Completed Terminée 2026-06-10T18:30:21.24 Completed 0 30564 Standing Committee on Health Comité permanent de la santé HESA Standing Committee on Health 6 false true false false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 120 2026-05-08T00:00:00 true Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 133 2026-06-10T00:00:00 true 13570722 13961660 2nd reading and referral to committee - HESA 2e lecture et renvoi en comité - HESA 2nd reading and referral to committee - HESA 15 Agreed To Adoptée Agreed To 9 On division Avec dissidence On division 2026-06-10T00:00:00 133 60112 0 Placed in the Order of Precedence Ajouté à l'Ordre de priorité Placed in the Order of Precedence 2026-03-19T00:00:00 false false 60121 0 Second reading and referral to committee Deuxième lecture et renvoi en comité Second reading and referral to committee 2026-06-10T00:00:00 true false 60121 Second reading and referral to committee Deuxième lecture et renvoi en comité Second reading and referral to committee 2026-06-10T18:30:21.24 2026-06-10T18:30:21.24 1 2026-06-10T18:30:21.24 0 1 13509406 60152 Sponsor’s speech Discours du parrain Sponsor’s speech 105437 Marcus Powlowski Marcus Powlowski Liberal Libéral Liberal 45 1 120 2026-05-08T13:16:59 0 1 13509431 60153 Response speech Discours en réponse Response speech 123500 Burton Bailey Burton Bailey Conservative Conservateur Conservative 45 1 120 2026-05-08T13:36:29 0 1 13509441 60153 Response speech Discours en réponse Response speech 104773 Mario Simard Mario Simard Bloc Québécois Bloc Québécois Bloc Québécois 45 1 120 2026-05-08T13:46:52 false false 60049 Consideration in committee Examen en comité Consideration in committee 1 45 1 2 No activity Aucune activité No activity 0 30564 Standing Committee on Health Comité permanent de la santé HESA Standing Committee on Health 6 false true false false 0 false false 60032 Report stage Étape du rapport Report stage 0 0 0 1 Not reached Non atteinte Not reached 0 false false 60031 Third reading Troisième lecture Third reading 0 0 0 1 Not reached Non atteinte Not reached 0 false false 60029 First reading Première lecture First reading 0 0 0 1 Not reached Non atteinte Not reached 0 false false 60030 Second reading Deuxième lecture Second reading 0 0 0 1 Not reached Non atteinte Not reached 0 false false 60031 Third reading Troisième lecture Third reading 0 0 0 1 Not reached Non atteinte Not reached 0 false false 13962523 80701 First Reading Première lecture First Reading 0 Health Canada. Special Access Program for Drugs: Guidance Document for Industry and Practitioners, Guidance Document, Revised: January 2022. Santé Canada. Programme d’accès spécial aux médicaments : Ligne directrice à l’intention de l’industrie et des praticiens, Ligne directrice, Date de révision : avril 2022. 8 Related Links Liens connexes Related Links https://publications.gc.ca/collections/collection_2022/sc-hc/H164-303-2022-eng.pdf https://publications.gc.ca/collections/collection_2022/sc-hc/H164-303-2022-fra-1.pdf https://publications.gc.ca/collections/collection_2022/sc-hc/H164-303-2022-eng.pdf 0 Health Canada. Special access drugs: Most often requested. Santé Canada. Médicaments d’accès spécial : Les plus souvent demandés. 8 Related Links Liens connexes Related Links https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs-most-often-requested.html https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/acces-special/medicaments-plus-souvent-demandes.html https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs-most-often-requested.html 0 Health Canada. Information for patients on the Special Access Program. Santé Canada. Information pour les patients sur le Programme d’accès spécial. 8 Related Links Liens connexes Related Links https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/information-patients.html https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/acces-special/information-patients.html https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/information-patients.html false true